Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/08/2878309/0/en/SCYNEXIS-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/30/2872763/0/en/SCYNEXIS-Presented-Preclinical-Data-on-Second-Generation-Fungerp-SCY-247-at-the-Congress-of-the-European-Society-of-Clinical-Microbiology-and-Infectious-Diseases-ESCMID-Global-Form.html
https://www.globenewswire.com/news-release/2024/04/09/2860345/0/en/SCYNEXIS-to-Present-Preclinical-Data-on-Second-Generation-Fungerp-SCY-247-at-the-34th-European-Congress-of-Clinical-Microbiology-and-Infectious-Diseases-ECCMID.html
https://www.globenewswire.com/news-release/2024/03/28/2854435/0/en/SCYNEXIS-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/01/30/2820499/0/en/SCYNEXIS-to-Participate-in-Guggenheim-s-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com/news-release/2024/01/29/2819465/0/en/SCYNEXIS-Presented-Preclinical-Data-on-Second-Generation-Fungerp-SCY-247-against-Mucormycosis-at-the-11th-Advances-Against-Aspergillosis-and-Mucormycosis-Conference.html
https://www.globenewswire.com//news-release/2024/01/05/2804637/0/en/SCYNEXIS-to-Present-Preclinical-Data-on-Second-Generation-Fungerp-SCY-247-at-the-11th-Advances-Against-Aspergillosis-and-Mucormycosis-Conference-January-25-27-in-Milan-Italy.html
https://www.fiercepharma.com/pharma/gsk-downgrades-milestone-payments-scynexis-antifungal-recall-drags-2024
https://www.globenewswire.com//news-release/2023/11/13/2779588/0/en/SCYNEXIS-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-18-2023-24260.pdf